3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Polycystic Ovary Syndrome
2
Uterine Anomalies
1
Salpingitis
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Leiomyoma
1
Infertility, Female
1
Infertility
1
Endometritis
1
Endometriosis
1
Interventions
estradiol, norethindrone drug combination
9
asoprisnil
9
Uterine Myomectomy
9
telapristone acetate
8
Uterine Artery Embolization
8
ulipristal acetate
7
relugolix
7
elagolix
7
Estradiol
7
vilaprisan
5
Norethindrone Acetate
5
Mifepristone
5
ulipristal
4
linzagolix
4
Leuprolide
4
Tranexamic Acid
3
Sodium Chloride
3
Hysterectomy
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Saline Solution
2
Radiofrequency Ablation
2
Progestins
2
Lidocaine
2
Letrozole
2
Goserelin
2
Endometrial Ablation Techniques
2
Anesthesia, General
2
pirfenidone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leiomyoma
×
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled